**Core Concept**
Primary biliary cirrhosis (PBC), also known as primary biliary cholangitis, is a chronic autoimmune liver disease characterized by progressive destruction of the intrahepatic bile ducts, leading to cholestasis and eventually cirrhosis. The underlying pathophysiology involves a complex interplay between genetic predisposition, environmental triggers, and immune system dysregulation.

**Why the Correct Answer is Right**
The correct answer is associated with the presence of antimitochondrial antibodies (AMA), which are highly specific for PBC. The AMA targets the E2 subunit of pyruvate dehydrogenase complex (PDC-E2), a mitochondrial enzyme involved in the breakdown of pyruvate to acetyl-CoA. This immune response leads to the destruction of intrahepatic bile ducts and subsequent liver damage. The presence of AMA is a hallmark diagnostic feature of PBC.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because PBC is not primarily associated with chronic hepatitis B or C infection, which are distinct liver diseases characterized by viral replication and inflammation.
**Option B:** This option is incorrect because autoimmune hepatitis is a separate entity characterized by inflammation and damage to the liver parenchyma, rather than bile duct destruction.
**Option C:** This option is incorrect because primary sclerosing cholangitis is a distinct disease characterized by inflammation and scarring of the intrahepatic and extrahepatic bile ducts, often associated with inflammatory bowel disease.

**Clinical Pearl / High-Yield Fact**
The presence of AMA is a critical diagnostic clue for PBC, and serological testing for these antibodies is an essential component of the diagnostic workup. A positive AMA titer can help differentiate PBC from other causes of liver disease.

**Correct Answer:** A. Antimitochondrial antibodies.